379 related articles for article (PubMed ID: 23760288)
1. Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus.
Cherney DZ; Zinman B; Kennedy CR; Moineddin R; Lai V; Yang S; Miller JA; Prokopec SD; Boutros PC; Scholey JW; Reich HN
Kidney Int; 2013 Dec; 84(6):1246-53. PubMed ID: 23760288
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ
Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
4. Renin-Angiotensin system blockade for diabetic nephropathy prevention.
Naviglio S; Pirozzi F
Am J Cardiol; 2010 May; 105(10):1505. PubMed ID: 20451706
[No Abstract] [Full Text] [Related]
5. The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetes.
Cherney DZ; Scholey JW; Jiang S; Har R; Lai V; Sochett EB; Reich HN
Diabetes Care; 2012 Nov; 35(11):2324-30. PubMed ID: 22837362
[TBL] [Abstract][Full Text] [Related]
6. Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes.
Komers R; Simkova R; Kazdova L; Ruzickova J; Pelikanova T
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):33-8. PubMed ID: 15136972
[TBL] [Abstract][Full Text] [Related]
7. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes.
Cherney DZ; Sochett EB; Miller JA
Kidney Int; 2005 Oct; 68(4):1722-8. PubMed ID: 16164648
[TBL] [Abstract][Full Text] [Related]
9. Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study.
Cherney DZ; Reich HN; Scholey JW; Lai V; Slorach C; Zinman B; Bradley TJ
Can J Physiol Pharmacol; 2012 Jan; 90(1):113-21. PubMed ID: 22188532
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
[TBL] [Abstract][Full Text] [Related]
11. Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review.
Sjølie AK; Dodson P; Hobbs FR
Int J Clin Pract; 2011 Feb; 65(2):148-53. PubMed ID: 21235695
[TBL] [Abstract][Full Text] [Related]
12. Renin release in response to Renin system blockade: activation of the Renin system in type 1 diabetes mellitus.
Stevanovic RD; Price DA; Lansang MC; Fisher ND; Laffel LM; Hollenberg NK
J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):78-83. PubMed ID: 16470486
[TBL] [Abstract][Full Text] [Related]
13. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
[TBL] [Abstract][Full Text] [Related]
14. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
[TBL] [Abstract][Full Text] [Related]
15. Clinical and hemodynamic effects of renin-angiotensin system blockade in cardiac transplant recipients.
Karabsheh S; Verma DR; Jain M; Stoddard G; Brunisholz K; Stehlik J; Kfoury A; Gilbert E; Bader F
Am J Cardiol; 2011 Dec; 108(12):1836-9. PubMed ID: 22133132
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system (RAS) blockade attenuates growth and metastatic potential of renal cell carcinoma in mice.
Araújo WF; Naves MA; Ravanini JN; Schor N; Teixeira VP
Urol Oncol; 2015 Sep; 33(9):389.e1-7. PubMed ID: 25595575
[TBL] [Abstract][Full Text] [Related]
17. Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.
Rashtchizadeh N; Aghaeishahsavari M; Argani H; Noroozianavval M; Veisi P; Ghorbanihaghjo A
Clin Biochem; 2007 Feb; 40(3-4):194-200. PubMed ID: 17222813
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
19. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
Bilous R
Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
[No Abstract] [Full Text] [Related]
20. Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
Krairittichai U; Chaisuvannarat V
J Med Assoc Thai; 2009 May; 92(5):611-7. PubMed ID: 19459520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
